These findings regarding BMPR2 mutations in IPAH patients and development of IPAH among individuals with BMPR2 mutations suggest that unrevealed signal transduction pathways are responsible for IPAH pathogenesis, either in cooperation with, or independent of, dysfunction in TGFβ systems [9]. This evidence concerns the gene BMPR2 and idiopathic pulmonary arterial hypertension.